Citation Impact
Citing Papers
Behavioral risks associated with tattooing.
2003
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
The state of mental health in old‐age across the ‘old’ European Union – a systematic review
2005
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Interindividual Variability of the Clinical Pharmacokinetics of Methadone
2002
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
Tattoos and body piercings in the United States: A national data set
2006 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls.
1999 Standout
Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts
1995
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
Prefrontal and temporal gray matter density decreases in opiate dependence
2005
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex
2002 Standout
Self-reported psychotropic drug use and associated factors in a French community sample
1992
Development of the EURO–D scale – a European Union initiative to compare symptoms of depression in 14 European centres
1999 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Prevalence and predictors of depression in populations of elderly: a review
2006 Standout
Triadic model of the neurobiology of motivated behavior in adolescence
2005 Standout
Mental Disorders and the Use of Psychotropic Drugs in an 85-Year-Old Urban Population
1993
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
The size and burden of mental disorders and other disorders of the brain in Europe 2010
2011 Standout
Effective Medical Treatment of Opiate Addiction
1998
Relating protein pharmacology by ligand chemistry
2007 Standout
Psychische Störungen in der Allgemeinbevölkerung
2014 Standout
KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING
2008
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Drug Dependence, a Chronic Medical Illness
2000 Standout
Drug addiction as dopamine-dependent associative learning disorder
1999
Nucleus accumbens shell and core dopamine: differential role in behavior and addiction
2002
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Dopamine, learning and motivation
2004 Standout
The Clinical Opiate Withdrawal Scale (COWS)
2003 Standout
A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
1998
Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
2007
Three Methods of Opioid Detoxification in a Primary Care Setting
1997
Pharmacologic treatments for opioid dependence: detoxification and maintenance options
2007
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Buprenorphine treatment of opioid dependence: A review.
1995
Works of Norbert Loimer being referenced
Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users
1992
Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels
1991
Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment
1989
5-Hydroxy-indolacetic-acid (5-HIAA) serum levels in depressive patients and ECT
1996
The use of plasma levels to optimize methadone maintenance treatment
1992
The Prevalence of Psychoactive Drug Intake in a Metropolitan Population
1989
Acute Blocking of Naloxone-Precipitated Opiate Withdrawal Symptoms by Methohexitone
1990
Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification
1991
Tattooing and high-risk behaviour among drug addicts.
1992
Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates
1991